Descriptor English: | Ethinyl Estradiol | ||||||
Descriptor Spanish: |
Etinilestradiol
| ||||||
Descriptor Portuguese: | Etinilestradiol | ||||||
Descriptor French: | Éthinyloestradiol | ||||||
Entry term(s): |
19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)- Estinyl Estradiol, Ethinyl Estradiol, Ethynyl Ethinyl Estradiol Hemihydrate Ethinyl Estradiol, (8 alpha)-Isomer Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer Ethinyl Estradiol, (9 beta,17 alpha)-Isomer Ethinyl Oestradiol Effik Ethinyl-Oestradiol Effik Ethinylestradiol Jenapharm Ethinyloestradiol Ethynyl Estradiol Hemihydrate, Ethinyl Estradiol Jenapharm, Ethinylestradiol Lynoral Microfollin Microfollin Forte Progynon C |
||||||
Tree number(s): |
D04.210.500.668.651.568.291 D06.472.334.851.437.968.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004997 | ||||||
Scope note: | A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Estrogens |
||||||
Registry Number: | 423D2T571U | ||||||
CAS Type 1 Name: | 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)- | ||||||
DeCS ID: | 5089 | ||||||
Unique ID: | D004997 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1966/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2019/07/08 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Ethinyl Estradiol
- Preferred
Ethinyl Estradiol Hemihydrate
- Narrower
Ethinyl Estradiol, (8 alpha)-Isomer
- Narrower
Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer
- Narrower
Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer
- Narrower
Progynon C
- Narrower
Microfollin
- Narrower
Microfollin Forte
- Narrower
Ethinyl-Oestradiol Effik
- Narrower
Ethinylestradiol Jenapharm
- Narrower
Lynoral
- Narrower
Estinyl
- Narrower
Ethinyl Estradiol, (9 beta,17 alpha)-Isomer
- Narrower
Concept UI |
M0007862 |
Scope note | A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. |
Preferred term | Ethinyl Estradiol |
Entry term(s) |
19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)- Estradiol, Ethinyl Estradiol, Ethynyl Ethinyloestradiol Ethynyl Estradiol |
Concept UI |
M0330359 |
Preferred term | Ethinyl Estradiol Hemihydrate |
Entry term(s) |
Hemihydrate, Ethinyl Estradiol |
Concept UI |
M0330361 |
Preferred term | Ethinyl Estradiol, (8 alpha)-Isomer |
Concept UI |
M0330357 |
Preferred term | Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer |
Concept UI |
M0330356 |
Preferred term | Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer |
Concept UI |
M0477807 |
Preferred term | Progynon C |
Concept UI |
M0007863 |
Preferred term | Microfollin |
Concept UI |
M0007864 |
Preferred term | Microfollin Forte |
Concept UI |
M0477804 |
Preferred term | Ethinyl-Oestradiol Effik |
Entry term(s) |
Ethinyl Oestradiol Effik |
Concept UI |
M0477805 |
Preferred term | Ethinylestradiol Jenapharm |
Entry term(s) |
Jenapharm, Ethinylestradiol |
Concept UI |
M0477806 |
Preferred term | Lynoral |
Concept UI |
M0007865 |
Preferred term | Estinyl |
Concept UI |
M0330360 |
Preferred term | Ethinyl Estradiol, (9 beta,17 alpha)-Isomer |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey